Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Cancer|July 27, 2004
Monoclonal gammopathy of undetermined significance and multiple myeloma are associated with an increased incidence of venothromboembolic diseaseGordan Srkalovic, Marte G Cameron, Lisa Rybicki, et al.
Expert Opinion on Biological Therapy|January 17, 2007
Alfimeprase: a novel recombinant direct-acting fibrinolyticSteven R Deitcher, Walter D Funk, James Buchanan, et al.
The Prostate|October 18, 2006
Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family historyEric Jorgenson, Steven R Deitcher, Mine Cicek, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|September 10, 2002
Detection of a novel point mutation of the prothrombin gene at position 20209Ilka Warshawsky, Carol Hren, Linda Sercia, et al.
Melanoma Research|November 18, 2008
A pilot study with vincristine sulfate liposome infusion in patients with metastatic melanomaAgop Y Bedikian, Nicholas E Papadopoulos, Kevin B Kim, et al.
Digestive Diseases and Sciences|November 9, 2007
To clot or not to clot: are there predictors of clinically significant thrombus formation in patients with gastroparesis and prolonged IV access?W Bradley Creel, Thomas L Abell, Amy Lobrano, et al.
Cancer|June 19, 2009
Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non-Hodgkin lymphoma: report of the pivotal phase 2 studyM A Rodriguez, Robert Pytlik, Tomas Kozak, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 15, 2014
High-dose vincristine sulfate liposome injection (Marqibo) Is not associated with clinically meaningful hematologic toxicityOlivia R Deitcher, John Glaspy, Rene Gonzalez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Safety and efficacy of alteplase for restoring function in occluded central venous catheters: results of the cardiovascular thrombolytic to open occluded lines trialSteven R Deitcher, Mark R Fesen, Paul M Kiproff, et al.
Journal of Vascular and Interventional Radiology : JVIR|June 5, 2004
Dose-ranging trial with a recombinant urokinase (urokinase alfa) for occluded central venous catheters in oncology patientsSteven R Deitcher, Giuseppe Fraschini, Jonathan Himmelfarb, et al.
Pageof 5